Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Kidney Injury and Intermittent Dialysis Dose

NCT07924137 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07924137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Kidney Injury and Intermittent Dialysis Dose
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
January 1, 2028
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, critical illness, intensive care (icu), renal dialysis, renal replacement therapy

Arms

As registered; 1 arm.

  • Patients on intermittent hemodialysis Intermittent hemodialysis (no study-assigned intervention)

    Adult ICU patients with KDIGO stage 3 AKI treated with IHD, either first-line or following continuous kidney replacement therapy.

    In these patients, the study assesses the agreement between different measures of dialysis dose (Kt/Vd, double-pool Kt/Vd, Kt, URR, SRI).

Primary endpoints

Registered primary outcome measures; 5 primary.

  • Kt: volume of blood totally cleared of urea during the session (L) Up to 30 days

    Quantitative value of each dialysis dose parameter, measured at each dialysis session

  • Kt/Vd: Kt divided by the patient's urea distribution volume (Vd, L) Up to 30 days

    Quantitative value of each dialysis dose parameter, measured at each dialysis session

  • Double-pool Kt/Vd: Kt/Vd calculated with a double-pool urea kinetic model Up to 30 days

    Quantitative value of each dialysis dose parameter, measured at each dialysis session

  • URR: urea reduction ratio, based on post-dialysis plasma urea Up to 30 days

    Quantitative value of each dialysis dose parameter, measured at each dialysis session

  • SRI: solute removal index, based on urea in the effluent Up to 30 days

    Quantitative value of each dialysis dose parameter, measured at each dialysis session

Lead sponsor's other trials

Assistance Publique - Hôpitaux de Paris, most recent start first.

Similar trials

Same condition (Acute Kidney Injury) and phase, most recent start first.